What was tested
Seyed Amir Abas Noorbakhsh and colleagues at Rafsanjan University of Medical Sciences isolated mesenchymal stem cells from the pulp of permanent teeth (DPSCs) and from exfoliated deciduous teeth (SHED), with ethics approval IR.RUMS.REC.1402.141 from the university’s review board (DOI 10.1007/s10528-026-11411-4, Biochemical Genetics 64(5):7720-7742, Epub 12 June 2026). Both cell types were characterized by flow cytometry, then compared on colony formation, population doubling time, viability, adipogenic and osteogenic differentiation, alkaline phosphatase (ALP) activity after osteogenic induction, and expression of stemness genes (SOX2, OCT4, NANOG) and differentiation genes (OCN, DSPP, AMBN, SPARC, IBSP).
What they found
SHED formed more colonies than DPSCs (33.66 vs 28.33 on the colony-formation assay) and divided faster, with a doubling time of 33.13 h against 39.25 h. After osteogenic induction, SHED showed significantly higher ALP activity, an early osteogenic readout. On expression, SHED ran higher on the three stemness genes (OCT4, NANOG, SOX2) and on AMBN and OCN, while DPSCs ran higher on DSPP, SPARC and IBSP. The authors’ reading: SHED tilt toward bone and enamel-like tissue formation, DPSCs toward dentin-pulp complex repair.
What it does not show
Everything is in vitro, from one lab, and the abstract of record reports no donor count, no group size and no statistical detail, so the colony and doubling-time figures cannot be weighed for precision. There is no repair outcome anywhere in the design: no dentin deposition assay, no ectopic or orthotopic animal model, no clinical endpoint. The “which cell for which tissue” conclusion is a rationale built on the direction of marker expression, not a demonstrated match. Two marker choices deserve skepticism. SPARC and IBSP are broadly osteogenic markers in the bone literature, so grouping them with the dentin-specific DSPP as “odontogenic” partly reflects panel construction rather than lineage. And AMBN (ameloblastin) is an enamel-matrix protein of epithelial origin, so its higher expression in mesenchymal pulp cells is a result the full text would need to validate at the assay level before it can carry the “enamel-like” reading.
Where it sits in the field
For the pulp and dentin repair program, the DPSC-versus-SHED question is a live design choice in every cell-based pulp repair protocol, and this paper adds a current datapoint in SHED’s favor on proliferation and early osteogenic activity, consistent with earlier comparative work (Govindasamy et al. 2010, J Endod; Sabbagh et al. 2020, J Dent). It does not settle the choice: the program’s own recent record runs the other way on repair relevance, with DPSC-based constructs producing pulp-like tissue in large-animal pulpotomy models while no SHED arm has been run head-to-head in vivo. The current field assessment stands at /field/.
Where we differ from the coverage
We found no press or popular coverage of this paper to differ from. Against the paper’s own framing, we decline to promote the conclusion from marker pattern to cell-selection rule. The abstract’s summary, SHED for bone and enamel-like regeneration, DPSCs for dentin-pulp repair, is a hypothesis the study’s in vitro expression design cannot test; on the evidence stated, what was shown is faster-growing deciduous-pulp cells with stronger early osteogenic enzyme activity, and permanent-pulp cells with higher dentin-gene expression.
Provenance: grounded in the abstract of record (PubMed PMID 42283766, retrieved 20 October 2026); the publisher full text is paywalled and was not read, so every number above comes from the abstract, and donor counts, statistics and assay details could not be independently checked. Method and sourcing standard at /method/.